Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Chung Tse, MD
CONTACT
Maureen DeMarshall, BSN, RN
CONTACT
Lead
University of Pennsylvania
Subjects will be screened and enrolled once PI confirms eligibility. After patient signs consent: Duloxetine 30 mg orally daily will be administered for 1 week (age \<65 years) or 2 weeks (age ≥65 years), then increased to duloxetine 60 mg orally daily, if tolerated. Patients may continue duloxetine 30 mg if they do not tolerate duloxetine 60 mg. Patients will receive 30-60 mg of duloxetine for 6 weeks, followed by a tapering period of 2 weeks at the end of treatment, mailed to their home address. Patients who wish to continue taking duloxetine after the trial may contact their primary care provider to obtain a prescription for duloxetine. Patient reported outcomes will be completed at set intervals.
Age
24–any
Sex
ALL
Healthy volunteers
Not accepted
